Literature DB >> 21465536

Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells.

Youqiang Li1, Yu Zeng, Steven M Mooney, Bo Yin, Atsushi Mizokami, Mikio Namiki, Robert H Getzenberg.   

Abstract

The microenvironment is central to many aspects of cancer pathobiology and has been proposed to play a role in the development of cancer cell resistance to therapy. To examine the response to microenvironmental conditions, two paclitaxel resistant prostate cancer (PCa) cell lines (stable and reversible) and one reversible heat resistant cell line were studied. In comparison to their parental cell lines, both paclitaxel resistant cell lines (stable and reversible) were more sensitive to microenvironmental heat, potentially yielding a synergistic therapeutic opportunity. In the two phenotypic cells repopulated after acute heat or paclitaxel treatments, there was an inverse correlation between paclitaxel and heat resistance: resistance to paclitaxel imparted sensitivity to heat; resistance to heat imparted sensitivity to paclitaxel. These studies indicate that as cancer cells evolve resistance to single microenvironmental stress they may be more sensitive to others, perhaps allowing us to design new approaches for PCa therapy.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21465536      PMCID: PMC3406746          DOI: 10.1002/jcb.23134

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  39 in total

Review 1.  Stress and the epigenetic landscape: a link to the pathobiology of human diseases?

Authors:  Sarah E Johnstone; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2010-10-05       Impact factor: 53.242

Review 2.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

3.  On the mechanism of fluid exchange of tissues in vitro.

Authors:  A LEAF
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

Review 4.  Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect".

Authors:  Donald S Coffey; Robert H Getzenberg; Theodore L DeWeese
Journal:  JAMA       Date:  2006-07-26       Impact factor: 56.272

5.  Distinct epigenetic changes in the stromal cells of breast cancers.

Authors:  Min Hu; Jun Yao; Li Cai; Kurt E Bachman; Frédéric van den Brûle; Victor Velculescu; Kornelia Polyak
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

6.  Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines.

Authors:  B R Pflug; R E Reiter; J B Nelson
Journal:  Prostate       Date:  1999-09-01       Impact factor: 4.104

7.  Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas.

Authors:  A Becker; P Stadler; R S Lavey; G Hänsgen; T Kuhnt; C Lautenschläger; H J Feldmann; M Molls; J Dunst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

8.  The role of protein accumulation on the kinetics of entry into S phase following extreme hypoxia.

Authors:  O Amellem; E O Pettersen
Journal:  Anticancer Res       Date:  1991 May-Jun       Impact factor: 2.480

9.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Authors:  Ian F Tannock; Ronald de Wit; William R Berry; Jozsef Horti; Anna Pluzanska; Kim N Chi; Stephane Oudard; Christine Théodore; Nicholas D James; Ingela Turesson; Mark A Rosenthal; Mario A Eisenberger
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

Review 10.  Apoptosis-modulating agents in combination with radiotherapy-current status and outlook.

Authors:  Claus Belka; Verena Jendrossek; Martin Pruschy; Stefan Vink; Marcel Verheij; Wilfried Budach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

View more
  10 in total

Review 1.  Changing the energy habitat of the cancer cell in order to impact therapeutic resistance.

Authors:  Robert H Getzenberg; Donald S Coffey
Journal:  Mol Pharm       Date:  2011-09-29       Impact factor: 4.939

2.  The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor.

Authors:  Steven M Mooney; Princy Parsana; James R Hernandez; Xin Liu; James E Verdone; Gonzalo Torga; Calvin A Harberg; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

3.  Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines.

Authors:  Hale Samli; Murat Samli; Buse Vatansever; Sena Ardicli; Nazlihan Aztopal; Deniz Dincel; Ahmet Sahin; Faruk Balci
Journal:  World J Urol       Date:  2018-09-22       Impact factor: 4.226

4.  Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer.

Authors:  John J Kim; Bo Yin; Christhunesa S Christudass; Naoki Terada; Krithika Rajagopalan; Ben Fabry; Danielle Y Lee; Takumi Shiraishi; Robert H Getzenberg; Robert W Veltri; Steven S An; Steven M Mooney
Journal:  J Cell Biochem       Date:  2013-06       Impact factor: 4.429

5.  CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers.

Authors:  John J Kim; Krithika Rajagopalan; Basil Hussain; Brenten H Williams; Prakash Kulkarni; Steven M Mooney
Journal:  Biomark Res       Date:  2013-06-13

6.  Slug contributes to cancer progression by direct regulation of ERα signaling pathway.

Authors:  Youqiang Li; Yanyuan Wu; Thomas C Abbatiello; Warren L Wu; Ju Ri Kim; Marianna Sarkissyan; Suren Sarkissyan; Seyung S Chung; Yahya Elshimali; Jaydutt V Vadgama
Journal:  Int J Oncol       Date:  2015-02-05       Impact factor: 5.650

7.  A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.

Authors:  Naomi Harner-Foreman; Jayakumar Vadakekolathu; Stéphanie A Laversin; Morgan G Mathieu; Stephen Reeder; A Graham Pockley; Robert C Rees; David J Boocock
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

8.  Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.

Authors:  Princy Parsana; Sarah R Amend; James Hernandez; Kenneth J Pienta; Alexis Battle
Journal:  BMC Cancer       Date:  2017-06-26       Impact factor: 4.430

9.  Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells.

Authors:  Ashish Kumar; Pawan Kumar; Mitu Sharma; Susy Kim; Sangeeta Singh; Steven J Kridel; Gagan Deep
Journal:  Cancer Drug Resist       Date:  2022-06-21

Review 10.  Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.

Authors:  Takeshi Namekawa; Kazuhiro Ikeda; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Cells       Date:  2019-01-20       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.